Healthcare & Life Sciences · Agent 05 · on IBM watsonx Orchestrate

Kill the bad molecule early.

In plain English: most drug candidates fail — and the late they fail, the more they cost. Quantum Pharma runs the classical pre-screens (RDKit / Biopython) that wash out the non-starters fast, then routes the quantum-heavy steps to real IBM Heron. Every screen is sealed with a hybrid post-quantum signature chain.

18
drug-discovery tools
GPT-OSS
120B model
RDKit
+ real IBM Heron
7 yr
WORM · 17a-4(f) / 4511
The problem we exist to solve

Nine in ten candidates fail. The expensive ones fail last.

01 · Late

Failure in the clinic costs billions

A molecule that washes out in Phase II took years and a fortune to get there. The cheapest failure is the one you catch at the bench.

02 · Vast

The search space is astronomical

There are more drug-like molecules than atoms in the solar system. You can't synthesize your way through it — you have to screen first.

03 · Unaudited

Regulators want the trail

FDA GxP and 21 CFR Part 11 want every screen, every decision, immutable. A result you can't re-derive is a result a regulator won't accept.

01 · What it screens

Screen, predict, optimize, fold.

Deterministic RDKit pre-screens as the source of truth, with quantum lead-optimization routed to a real IBM QPU — disclosing real_backend_resolved:false whenever it serves a classical baseline.

Candidate & virtual screening

Wash out the non-starters fast — drug-likeness, virtual screening, ADMET safety prediction at the bench.

drug_candidate_screener · admet_predictor

Lead optimization

Improve the survivors — quantum-kernel lead optimization and binding-affinity estimation against the target.

QSVM lead-optbinding_affinity_estimator

Structure

Conformer search, protein-folding simulation and de-novo generation — the shapes that make or break a fit.

protein_folding_simulator · de_novo_generator

Safety & genomics

Drug-drug interaction analysis and genomic-variant screening — the safety signals that matter before the clinic.

drug_interaction_analyzer · genomic_variant_analyzer
02 · The discovery bench

Profile a candidate. Seal the verdict.

A working pre-screen bench. Enter a molecule's descriptors and it checks Lipinski's Rule of Five and Veber's rules, plots each property against its limit, flags the ADMET liabilities, and seals the screen — the deterministic gate that decides what's worth quantum lead-optimization.

admet_predictor · descriptors

Lipinski Ro5 · VeberDrug-like
0 violations
In-browser demonstration. The deterministic RDKit-style pre-screen, sealed locally with real WebCrypto SHA-256. The production agent runs the full pipeline and quantum lead-optimization on watsonx Orchestrate.
03 · How a screen is made

Pre-screen. Optimize. Seal.

01 · PRE-SCREEN
Classical gate

RDKit rules wash out the molecules that can't be oral drugs — fast, deterministic, recomputable by hand.

02 · OPTIMIZE
Quantum lead-opt

Survivors go to quantum-kernel lead optimization and binding-affinity estimation on a real IBM QPU when it earns escalation.

03 · SEAL
21 CFR 11 provenance

Every screen sealed with a hybrid post-quantum signature chain to one published provenance root — FDA-audit-ready.

Honest about the boundary. The worker is a domain / orchestration proxy; heavy quantum execution runs in the EpochCore fabric on real IBM Heron. It discloses real_backend_resolved:false when it serves a classical baseline. Signatures are deterministic and reproducible from public anchors — FRE 902(13)/902(14) self-authentication: any third party can re-derive and verify.
04 · The toolset

Eighteen tools. Bench to dossier.

Tool
What it does
drug_candidate_screener
Drug-likeness pre-screen across a candidate set.
admet_predictor
Absorption, distribution, metabolism, excretion, toxicity.
lead_optimizer · binding_affinity_estimator
Quantum-kernel lead optimization & affinity.
protein_folding_simulator · conformer_search
Structure prediction & conformer enumeration.
drug_interaction_analyzer
Flags drug-drug interaction liabilities.
clinical_trial_optimizer · pharma_compliance_engine
Trial design + FDA GxP / 21 CFR 11 alignment.
Sealed · Ed25519 + ML-DSA-65/87 + SLH-DSA-128f FDA GxPHIPAA21 CFR Part 11SEC 17a-4(f)FINRA 4511FIPS 203/204/205

Find the molecule worth making.

Add Quantum Pharma to your watsonx Orchestrate workspace, or let the Prompt Builder wire it into a screen-optimize-seal chain.

EpochCore, LLC · research tooling, not medical advice · quantdev@epochcoreqcs.com